合併症のない胆石疾患の治療における共同意思決定:横断的な試験試験試験
Martin Alavi Treider1, Simone Kienlin2, Thomas J Fyhn3
1Department for Gastrointestinal Surgery Oslo University Hospital Mailbox 4950 Nydalen Oslo 0424 Norway Faculty of Medicine University of Oslo Oslo Norway.
まとめ
胆石疾患の治療における共有意思決定 (SDM) は,知覚が異なるが,中程度の患者の関与を示している. より高いSDMスコアは,手術の選択と相関しており,ケアの一貫性を向上させる必要があることを示しています.
科学分野:
- 医療上の意思決定をする.
- 外科患者の介護をする.
- 医療サービス 研究 医療サービス
背景:
- 共有意思決定 (SDM) は,合併症のない胆石疾患の治療選択において,外科的および保守的な選択肢の両方が実行可能である場合に決定的に重要です.
- 患者の好みは,利用可能な選択肢の安全性を考えると,治療の決定の中心です.
研究 の 目的:
- 合併症のない胆石病の治療のための共同意思決定における患者の関与の程度を評価する.
- SDMに対する患者,外科医,外部の観察者の認識を比較する.
主な方法:
- ノルウェーの外科外科クリニックでの将来的なパイロット研究.
- 患者,外科医,専門家の評価者からのビデオ録音された診察とMAPPIN-SDMアンケートデータの分析.
- MAPPIN-SDMのスコアは11項目 (0-4),より高いスコアはより高いSDMを示しています.
主要な成果:
- 合併症のない胆石疾患の26人の患者が含まれており,68%が女性で,平均年齢は47.8歳でした.
- 全体的な平均MAPPIN-SDMスコアは2.6で,患者 (3.5) と外科医 (2.9) は観察者 (1.55; p < 0.001) よりも高いSDMを報告しました.
- 手術を受けた患者 (54%) は,保守的に管理された患者 (2.28; p < 0.001) よりもSDMスコア (2.89) が著しく高かった.
結論:
- 合併症のない胆石疾患の診察では,中程度のSDMが存在します.
- SDMの患者/外科医の認識と観察者の評価の間に顕著な不一致が認められた.
- より高いSDMは,外科治療の選択と関連しており,SDMの質と一貫性を高める戦略の必要性を強調しています.
関連する概念動画
Cross-Sectional Research
12.7K
In cross-sectional research, a researcher compares multiple segments of the population at the same time. If they were interested in people's dietary habits, the researcher might directly compare different groups of people by age. Instead of following a group of people for 20 years to see how their dietary habits changed from decade to decade, the researcher would study a group of 20-year-old individuals and compare them to a group of 30-year-old individuals and a group of 40-year-old...
12.7K
Finding Volume Using Cross-Sectional Area
99
For solids whose cross-sectional areas vary in a predictable way, volume can be determined by integrating these areas along an axis perpendicular to the slices. This approach is particularly useful for polyhedral solids, where classical geometric formulas may not be immediately applicable. A tetrahedron provides a clear example of how cross-sectional integration can be applied to a three-dimensional object with continuously changing geometry.Consider a tetrahedron with height h and a base that...
99
Profile Leveling and Cross Sections
1.7K
Profile leveling and cross-sections are surveying methods used to determine and document terrain elevations for infrastructure projects such as highways, railroads, canals, and pipelines. These methods provide data for earthwork planning and alignment of proposed routes. Profile leveling involves measuring elevations along a fixed line to create a vertical terrain profile. A surveyor sets up a leveling instrument at the benchmark (BM) and records a backsight (BS) to determine the...
1.7K
Spinal Cord: Cross-sectional Anatomy
5.0K
The cross-sectional anatomy of the spinal cord offers a detailed view of its complex structure and function within the central nervous system. At the core of the spinal cord lies the gray matter, characterized by its butterfly or "H"-shaped appearance in cross-section. This central region is enveloped by white matter, with the overall structure divided into symmetrical halves by the dorsal median sulcus and the ventral median fissure.
Gray Matter and its Components
Central to the gray matter is...
Gray Matter and its Components
Central to the gray matter is...
5.0K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
981
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
981


